EMGALITY should be discontinued if signs or symptoms of Raynaud's phenomenon develop, and patients should be evaluated by a healthcare provider if symptoms do not resolve
These findings should encourage regulatory agencies and clinicians to investigate further, given the heterogeneity of the human population. Depression was the most commonly reported adverse event associated with these drugs, followed by anxiety and suicidal ideation
FDA in December 2025
Introduction The number of patients with type 2 diabetes mellitus (T2DM) is increasing annually, which poses a global health threat and causes high health care costs, especially in the Asian region ( Nowadays, the treatment for T2DM is based on lifestyle changes, especially diet and antidiabetic oral agents, according to the needs of the patients
PLUS, for a limited time score a FREE tub of our electrolytes* + a FREE IV Drip* to help mitigate any potential side effects
Cells were seeded in six-well plates at 2 10 6 cells/well 48 h prior to experiments